Inaedis, Inc.

Inaedis, Inc. is a spin-out company from Princeton University developing a pharmaceutical platform changing the future of drug development, delivery, and distribution by powderizing life-saving vaccines and biologics. First developed by Princeton scientists during the Covid-19 pandemic, our goal is to give everyone access to the miracles of modern medicine. Our proprietary Rapid Room-Temperature Dehydration (RTAD) platform technology finally solves the global dilemma posed by the thermal stabilization requirements of life-saving heat and freeze-sensitive vaccines and biologics. Inaedis is led by its founders: CEO Dr. Maksim Mezhericher and Prof. Howard A. Stone and is backed by Roadrunner Venture Studios and Princeton Innovation Center.